STOCK TITAN

Dss Inc - DSS STOCK NEWS

Welcome to our dedicated page for Dss news (Ticker: DSS), a resource for investors and traders seeking the latest updates and insights on Dss stock.

DSS, Inc. (NYSE American: DSS) is a multinational conglomerate with a diversified business portfolio encompassing nine distinct divisions: Product Packaging, Biotechnology, Consumer Marketing, Commercial Lending, Securities and Investment Management, Alternative Trading, Secure Living, Digital Transformation, and Alternative Energy. Established over 25 years ago, DSS has a long-standing reputation in anti-counterfeit, authentication, and diversion protection technologies, offering custom solutions to safeguard against product diversion, counterfeit, theft, and other costly occurrences. Their innovative technologies, backed by numerous patents, are utilized by corporations, governments, and financial institutions worldwide.

Recently, DSS has focused on expanding its value through strategic acquisitions and periodic IPO spinoffs. Under the leadership of Frank Heuszel, DSS has built a diversified portfolio aimed at driving profitability and growth. Notable subsidiaries include DSS Wealth Management, which advises the AmericaFirst Quantitative Funds, and Premier Packaging, specializing in innovative fiber-based packaging solutions.

In recent developments, DSS appointed Jim Monaghan as Chief Operating Officer and Chief Compliance Officer, and Michael Cheah as Portfolio Manager & Head of Fixed Income at DSS Wealth Management. Both additions bring over 30 years of industry experience and are expected to enhance DSS's investment strategies and compliance standards. Moreover, DSS is preparing for the IPO of its subsidiary, Impact Biomedical, which promises to reinforce the company's growth trajectory.

DSS's recent accomplishments include a successful legal defense of their ‘040 patent in the Federal Circuit Court against Nichia Corp., further solidifying their strong IP portfolio. Additionally, Chairman Heng Fai Ambrose Chan's recent acquisition of 672,173 shares underscores his confidence in DSS's strategic direction and market potential.

For continuous updates and more detailed information, visit the official website at www.dssworld.com and follow their latest news and developments on Twitter at @docsecuritysys and @authentisuite.

Rhea-AI Summary
DSS, Inc. intends to cure the stock price deficiency and return to compliance with NYSE American standards. The company received a letter from the NYSE American stating that its securities have been selling for a low price per share for a substantial period of time. The company must effect a reverse stock split or demonstrate sustained price improvement by April 20, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.8%
Tags
none
-
Rhea-AI Summary
DSS, Inc. has filed a registration statement with the SEC for the proposed IPO of its subsidiary, Impact Biomedical, on the NYSE American exchange.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.52%
Tags
-
News
Rhea-AI Summary
DSS, Inc. CEO provides update on progress and expectations, highlights upcoming IPO of Impact Biomedical and growth in subsidiaries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.49%
Tags
none
Rhea-AI Summary
Jim Monaghan and Michael Cheah join DSS Wealth Management as COO and Portfolio Manager respectively.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.82%
Tags
none
-
Rhea-AI Summary
DSS announces distribution date for stock dividend of Impact BioMedical Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.14%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.21%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.73%
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.81%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
none

FAQ

What is the current stock price of Dss (DSS)?

The current stock price of Dss (DSS) is $0.94 as of February 21, 2025.

What is the market cap of Dss (DSS)?

The market cap of Dss (DSS) is approximately 7.4M.

What does DSS, Inc. specialize in?

DSS, Inc. specializes in anti-counterfeit, authentication, and diversion protection technologies, offering custom solutions to protect against product diversion, counterfeit, and theft.

What are the key divisions of DSS, Inc.?

DSS, Inc. operates in nine key divisions: Product Packaging, Biotechnology, Consumer Marketing, Commercial Lending, Securities and Investment Management, Alternative Trading, Secure Living, Digital Transformation, and Alternative Energy.

Who are the recent key hires at DSS Wealth Management?

Jim Monaghan has been appointed as Chief Operating Officer and Chief Compliance Officer, and Michael Cheah as Portfolio Manager & Head of Fixed Income at DSS Wealth Management.

What are some recent achievements of DSS, Inc.?

Recent achievements include the successful defense of their ‘040 patent in the Federal Circuit Court and significant revenue growth in their Product Packaging division.

What is the significance of the Impact Biomedical IPO?

The Impact Biomedical IPO is expected to reinforce DSS's growth by allowing shareholders to benefit from the subsidiary's success while maintaining consolidated financials within DSS.

How does DSS, Inc. enhance shareholder value?

DSS enhances shareholder value through strategic acquisitions, periodic IPO spinoffs, and building a diversified portfolio across high-growth sectors.

How can I stay updated on DSS, Inc. news?

You can stay updated by visiting the official website at www.dssworld.com and following their Twitter handles @docsecuritysys and @authentisuite.

What makes DSS, Inc.'s Product Packaging division unique?

Premier Packaging, a subsidiary of DSS, specializes in innovative fiber-based packaging solutions, offering sustainable alternatives to traditional plastic packaging.

Who is the CEO of DSS, Inc.?

Frank Heuszel is the CEO of DSS, Inc.

What recent investment did Chairman Heng Fai Ambrose Chan make in DSS?

Chairman Heng Fai Ambrose Chan recently acquired an additional 672,173 shares of DSS in an open market transaction, signaling strong confidence in the company's strategic direction.
Dss Inc

NYSE:DSS

DSS Rankings

DSS Stock Data

7.45M
2.70M
59.28%
2.44%
0.16%
Packaging & Containers
Paperboard Containers & Boxes
Link
United States
WEST HENRIETTA